Your selection
economic development, Innovation / 06.06.2019
Eckert & Ziegler will be admitted to SDax
Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry will be admitted to SDax as of 24 June 2019. This decision was announced by the Working Committee for Equity Indices at Deutsche Börse AG, Frankfurt / Main, after yesterday’s regular review of the small-cap index. In addition to the high transparency requirements of the Prime Standard, the Eckert & Ziegler shares thereby also fulfill the relevant index size criteria of market capitalization and liquidity.
“We are very delighted to be admitted to SDAX. It is a further confirmation of the successful development of our company in the recent years and the attractiveness of our share. In the future, Eckert & Ziegler will thus gain even more attention. I would like to thank all our employees for this great success”, explained Dr. Andreas Eckert, CEO of Eckert & Ziegler AG."
The SDax comprises 70 companies which rank below the companies in the MDax and fulfill the selection criteria defined by Deutsche Börse. These companies must be listed in the Prime Standard segment and must have a minimum free float of ten percent. The stocks that fulfill these requirements are selected for the index on the basis of two size criteria, market capitalization based on free float and trading volume.
About Eckert & Ziegler.
Eckert & Ziegler Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with around 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine.
Contributing to saving lives.
Overview News
News Buch Berlin
From cell biology to CRISPR/Cas – new knowledge for schools
The Life Science Learning Lab at the Berlin-Buch research campus offers both school students and teachers the opportunity to immerse themselves in science. This year, the facility celebrates its 25th ...
more ...ERC grants Berlin scientists € 2.5 million each
Neuroscientists Gary Lewin and James Poulet at the Max Delbrück Center for Molecular Medicine have won highly coveted and competitive ERC Advanced Grants to study pain and the neural mechanisms that u...
more ...The Protein Expert
Prof. Dr. Fan Liu from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has recently received several awards for her contributions to the field of cross-linking mass spectrometry.
more ...Events Buch Berlin
21.04.2024, 16:00
Großes Sinfoniekonzert "Durch die Nacht zum Licht"
Saisonauftakt der Bürgersinfonie mit Werken von Beethoven, Mendelssohn Bartholdy und Berwald
more ...23.04.2024, 11:00
Kostenlose öffentliche Fahrrad-Codierung
Das Präventionsteam des Polizeiabschnittes 14 ist auf dem Campus Berlin-Buch und codiert kostenlos Fahrräder
more ...06.05.2024, 09:00
Realtime PCR und digital PCR Kurs
Der RealTime PCR und Digital PCR Kurs richtet sich an erfahrene PCR Anwender*innen und an Einsteiger*innen. Wichtige PCR Grundlagen werden erörtert, bevor die RealTime PCR besprochen und Genexpression...
more ...